70 related articles for article (PubMed ID: 31202730)
1. Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literature.
Patel HD; Semerjian A; Gupta M; Pavlovich CP; Johnson MH; Gorin MA; Allaf ME; Pierorazio PM
Urol Oncol; 2019 Aug; 37(8):519-524. PubMed ID: 31202730
[TBL] [Abstract][Full Text] [Related]
2. Effect of lesion dimension on survival in patients with T1a renal cell carcinoma who underwent deferred surgery.
Wang L; Huang L; Lei L; Xu Y; Huang L; Liu H; Wang H; Liu D
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38546805
[TBL] [Abstract][Full Text] [Related]
3. Pathological nature of renal tumors - does size matter?
Kurban LAS; Vosough A; Jacob P; Prasad D; Lam T; Scott N; Somani BK
Urol Ann; 2017; 9(4):330-334. PubMed ID: 29118533
[TBL] [Abstract][Full Text] [Related]
4. Utilization of Re-VASC, the Novel Retroperitoneal Neovascularity Scoring System, for Characterization of T1a Small Renal Masses.
Fateri C; Roth B; Rao S; Peta A; Limfueco L; Bui TL; Kar N; Glavis-Bloom J; Cumpanas A; Landman J; Houshyar R
J Endourol; 2024 Mar; 38(3):301-305. PubMed ID: 38149604
[No Abstract] [Full Text] [Related]
5. Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes.
Xu W; Gaborieau V; Niman SM; Mukeria A; Liu X; Maremanda KP; Takakura A; Zaridze D; Freedman ML; Xie W; McDermott DF; Choueiri TK; Catalano PJ; Sabbisetti V; Bonventre JV; Pierorazio PM; Singla N; Brennan P; Bhatt RS
J Clin Oncol; 2024 May; ():JCO2300699. PubMed ID: 38701382
[TBL] [Abstract][Full Text] [Related]
6. Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.
Sanchez A; Feldman AS; Hakimi AA
J Clin Oncol; 2018 Dec; 36(36):3591-3600. PubMed ID: 30372390
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of small renal masses.
Sebastià C; Corominas D; Musquera M; Paño B; Ajami T; Nicolau C
Insights Imaging; 2020 May; 11(1):63. PubMed ID: 32372194
[TBL] [Abstract][Full Text] [Related]
8. 2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses.
Kauffman EC; Ball MW; Barod R; Capitanio U; Finelli A; Mir MC; Shuch B; Smaldone MC; Tran MGB; Pierorazio PM
Soc Int Urol J; 2022 Nov; 3(6):424-436. PubMed ID: 38836217
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas.
Nakashima K; Kitagawa Y; Izumi K; Mizokami A; Gabata T; Namiki M
Oncol Lett; 2016 May; 11(5):3189-3193. PubMed ID: 27123087
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes and chronic kidney disease on active surveillance outcomes for small renal masses: A cohort study.
Alcalá NE; Futral CD; Miller CA; Sinks AL; Clark PE; Roy OP
Indian J Urol; 2023; 39(2):142-147. PubMed ID: 37304981
[TBL] [Abstract][Full Text] [Related]
11. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
[TBL] [Abstract][Full Text] [Related]
12. Polarization-sensitive optical coherence tomography for renal tumor detection in
Yan F; Wang C; Yan Y; Zhang Q; Yu Z; Patel SG; Fung KM; Tang Q
Opt Lasers Eng; 2024 Feb; 173():. PubMed ID: 37982078
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid Carcinoma Metastasis to the Colon from a Small Renal Mass: Case Report with Review of Literature.
Patidar S; Menon AR; Sundersingh S; Seshadri RA; Raja A
J Kidney Cancer VHL; 2023; 10(4):7-12. PubMed ID: 37936865
[TBL] [Abstract][Full Text] [Related]
14. Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.
Deniffel D; McAlpine K; Harder FN; Jain R; Lawson KA; Healy GM; Hui S; Zhang X; Salinas-Miranda E; van der Kwast T; Finelli A; Haider MA
Eur Radiol; 2023 Aug; 33(8):5840-5850. PubMed ID: 37074425
[TBL] [Abstract][Full Text] [Related]
15. Differentiating Oncocytic Renal Tumors from Chromophobe Renal Cell Carcinoma: Comparison of Peak Early-phase Enhancement Ratio to Clinical Risk Factors and Rater Predictions.
Patel HD; Huai K; Elliott N; Thorson DL; Rac G; Picken MM; Quek ML; Bova D; Gupta GN
Eur Urol Open Sci; 2022 Dec; 46():8-14. PubMed ID: 36506255
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and effect on intraoperative blood loss and postoperative pain of patients undergoing retroperitoneal laparoscopic partial nephrectomy for complex renal tumors.
Guo Y; Xu Q; Chen B; Liu L; Wang Y; Zhu A; Tian L
World J Surg Oncol; 2021 Sep; 19(1):282. PubMed ID: 34537060
[TBL] [Abstract][Full Text] [Related]
17. Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers.
Patel SH; Singla N; Pierorazio PM
World J Urol; 2021 Aug; 39(8):2869-2874. PubMed ID: 34370079
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resection.
Fonseca RB; Straub Hogan MM; Kapp ME; Cate F; Coogan A; Arora S; Gordetsky J; Smelser WW; Clark PE; Cates J; Giannico GA
Urol Oncol; 2021 Jun; 39(6):371.e7-371.e15. PubMed ID: 33773915
[TBL] [Abstract][Full Text] [Related]
19. Quality Assessment of CEUS in Individuals with Small Renal Masses-Which Individual Factors Are Associated with High Image Quality?
Spiesecke P; Fischer T; Friedersdorff F; Hamm B; Lerchbaumer MH
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33348741
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
Fragkoulis C; Glykas I; Papadopoulos G; Ntoumas K
Br J Radiol; 2021 Feb; 94(1118):20201369. PubMed ID: 33332982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
